Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:10 pm Sale | 2024-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 985,000 9.900% | -23,599 (-2.34%) | Filing History |
| 2024-11-14 7:22 pm Purchase | 2024-09-30 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 1,008,599 8.800% | 756,829 (+300.60%) | Filing History |
| 2024-02-13 8:11 pm Purchase | 2023-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 251,770 9.900% | 251,770 (New Position) | Filing History |
| 2023-11-29 4:33 pm Purchase | 2023-11-22 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 450,000 9.900% | 450,000 (New Position) | Filing History |
| 2022-09-09 4:27 pm Purchase | 2022-08-25 | 13D | PaxMedica, Inc. Common Stock PXMD | TardiMed Sciences LLC | 452,809 63.400% | 452,809 (New Position) | Filing History |
| 2022-09-09 4:24 pm Purchase | 2022-08-25 | 13G | PaxMedica, Inc. Common Stock PXMD | Blue Cane Partners LLC | 69,118 9.900% | 69,118 (New Position) | Filing History |